336 related articles for article (PubMed ID: 8983063)
1. Alterations of the cadherin-catenin cell adhesion system in cancers.
Kanai Y; Oda T; Shimoyama Y; Ochiai A; Oyama T; Yoshiura K; Akimoto S; Yamada T; Hirohashi S
Princess Takamatsu Symp; 1994; 24():51-62. PubMed ID: 8983063
[TBL] [Abstract][Full Text] [Related]
2. A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.
Oyama T; Kanai Y; Ochiai A; Akimoto S; Oda T; Yanagihara K; Nagafuchi A; Tsukita S; Shibamoto S; Ito F
Cancer Res; 1994 Dec; 54(23):6282-7. PubMed ID: 7954478
[TBL] [Abstract][Full Text] [Related]
3. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers.
Hirohashi S
Verh Dtsch Ges Pathol; 2000; 84():28-32. PubMed ID: 11217445
[TBL] [Abstract][Full Text] [Related]
4. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
[TBL] [Abstract][Full Text] [Related]
5. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
[TBL] [Abstract][Full Text] [Related]
6. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin-catenin cell-cell adhesion complex and human cancer.
Wijnhoven BP; Dinjens WN; Pignatelli M
Br J Surg; 2000 Aug; 87(8):992-1005. PubMed ID: 10931041
[TBL] [Abstract][Full Text] [Related]
8. [Dysfunction of cadherin cell adhesion system in cancer invasion and metastasis].
Ochiai A
Gan To Kagaku Ryoho; 1999 Mar; 26(4):565-71. PubMed ID: 10097760
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
10. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
12. Cadherin and catenin alterations in human cancer.
Hajra KM; Fearon ER
Genes Chromosomes Cancer; 2002 Jul; 34(3):255-68. PubMed ID: 12007186
[TBL] [Abstract][Full Text] [Related]
13. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
[TBL] [Abstract][Full Text] [Related]
17. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
Tomlinson JS; Alpaugh ML; Barsky SH
Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364
[TBL] [Abstract][Full Text] [Related]
18. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness.
Shimoyama Y; Nagafuchi A; Fujita S; Gotoh M; Takeichi M; Tsukita S; Hirohashi S
Cancer Res; 1992 Oct; 52(20):5770-4. PubMed ID: 1394201
[TBL] [Abstract][Full Text] [Related]
19. [Dysfunction of E-cadherin due to mutation of beta-catenin in a scirrhous gastric cancer cell line].
Kawanishi J; Kato J; Sasaki K; Fujii S; Watanabe N; Niitsu Y
Nihon Rinsho; 1995 Jul; 53(7):1590-4. PubMed ID: 7629993
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]